nach oben

Urolithiasis

Erschienen in:

03.03.2017 | Original Paper

Prevalence of renal uric acid stones in the adult

verfasst von: Alberto Trinchieri, Emanuele Montanari

Erschienen in: Urolithiasis | Ausgabe 6/2017

Einloggen, um Zugang zu erhalten

Abstract

The aim of this study was to estimate uric acid renal stone prevalence rates of adults in different countries of the world. PubMed was searched for papers dealing with “urinary calculi and prevalence or composition” for the period from January 1996 to June 2016. Alternative searches were made to collect further information on specific topics. The prevalence rate of uric acid stones was computed by the general renal stone prevalence rate and the frequency of uric acid stones in each country. After the initial search, 2180 papers were extracted. Out of them, 79 papers were selected after the reading of the titles and of the abstracts. For ten countries, papers relating to both the renal stone prevalence in the general population and the frequency of uric stones were available. Additional search produced 13 papers that completed information on 11 more countries in 5 continents. Estimated prevalence rate of uric acid stones was >0.75% in Thailand, Pakistan, Saudi Arabia, Iran, South Africa (white population), United States and Australia; ranged 0.50–0.75% in Turkey, Israel, Italy, India (Southern), Spain, Taiwan, Germany, Brazil; and <0.50% in Tunisia, China, Korea, Japan, Caribe, South Africa (blacks), India (Northern). Climate and diet are major determinants of uric acid stone formation. A hot and dry climate increases fluid losses reducing urinary volume and urinary pH. A diet rich in meat protein causes low urinary pH and increased uric acid excretion. On the other hand, uric acid stone formation is frequently associated with obesity, metabolic syndrome and diabetes type 2 that are linked to dietary energy excess mainly from carbohydrate and saturated fat and also present with low urine pH values. An epidemic of uric acid stone formation could be if current nutritional trends will be maintained both in developed countries and in developing countries and the areas of greater climatic risk for the formation of uric acid stones will enlarge as result of the “global warming”.

Daudon M, Bader CA, Jungers P (1993) Urinary calculi: review and classification methods and correlations with etiology. Scanning Microsc 7:1081–1104PubMed

Grases F, Costa-Bauza A, Ramis M, Montesinos V, Conte A (2002) Simple classification of renal calculi closely related to their micromorphology and etiology. Clin Chem Acta 322: 29–36CrossRef

Moses R, Pais VM Jr, Ursiny M, Prien EL Jr, Miller N, Eisner BH (2015) Changes in stone composition over two decades: evaluation of over 10,000 stone analyses. Urolithiasis 43:135–139CrossRefPubMed

Stamatelou KK, Francis ME, Jones CA, Nyberg LM, Curhan GC (2003) Time trends in reported prevalence of kidney stones in the United States: 1976–1994. Kidney Int 63:1817–1823CrossRefPubMed

Scales CD Jr, Smith AC, Hanley JM, Saigal CS (2012) Urologic Diseases in America Project. Prevalence of kidney stones in the United States. Eur Urol 62:160–165CrossRefPubMedPubMedCentral

Reyes Rabanal L, Mirabal Martínez M, Strusser González R (2002) Clinico-epidemiologic behavior of urolithiasis in a rural Caribbean region. Arch Esp Urol 55:527–533PubMed

Choo-Kang E (2008) Chemical composition of urinary tract stones at the University Hospital of the West Indies. West Indian Med 57:427–30

Ancao MS, Novoa CG, Coelho STSN, Laranja SM, Sigulem D, Heilberg IP, Schor N (1994) The Brazilian Multicentric Study of Nephrolithiasis (Multilit). In: Ryall R, Bais R, Marshall VR, Rofe AM, Smith LH, Walker VR (eds.) Urolithiasis 2. Plenum Press, New York and London, pp 480–480CrossRef

da Silva SF, Silva SL, Daher EF, Silva Junior GB, Mota RM, Bruno da Silva CA (2009) Determination of urinary stone composition based on stone morphology: a prospective study of 325 consecutive patients in an emerging country. Clin Chem Lab Med 47:561–564CrossRefPubMed

10.

Hesse A, Brändle E, Wilbert D, Köhrmann KU, Alken P (2003) Study on the prevalence and incidence of urolithiasis in Germany comparing the years 1979 vs. 2000. Eur Urol 44:709–713CrossRefPubMed

11.

Knoll T, Schubert AB, Fahlenkamp D, Leusmann DB, Wendt-Nordahl G, Schubert G (2011) Urolithiasis through the ages: data on more than 200,000 urinary stone analyses. J Urol 185:1304–1311CrossRefPubMed

12.

Sánchez-Martín FM, Millán Rodríguez F, Esquena Fernández S, Segarra Tomás J, Rousaud Barón F, Martínez-Rodríguez R, Villavicencio Mavrich H (2007) Incidence and prevalence of published studies about urolithiasis in Spain. A review. Actas Urol Esp 31:511–520CrossRefPubMed

13.

Arias Fúnez F, García Cuerpo E, Lovaco Castellanos F, Escudero Barrilero A, Avila Padilla S, Villar Palasí J (2000) Epidemiology of urinary lithiasis in our Unit. Clinical course in time and predictive factors. Arch Esp Urol 53:343–347PubMed

14.

Croppi E, Ferraro PM, Taddei L, Gambaro G, GEA Firenze Study Group (2012) Prevalence of renal stones in an Italian urban population: a general practice-based study. Urol Res 40:517–22.CrossRefPubMed

15.

Trinchieri A, Rovera F, Nespoli R, Currò A (1996) Clinical observations on 2086 patients with upper urinary tract stone. Arch Ital Urol Androl 68:251–262iPubMed

16.

Akinci M, Esen T, Tellaloğlu S (1991) Urinary stone disease in Turkey: an updated epidemiological study. Eur Urol 20:200–203CrossRefPubMed

17.

Karabacak OR, Dilli A, Saltaş H, Yalçınkaya F, Yörükoğlu A, Sertçelik MN (2013) Stone compositions in Turkey: an analysis according to gender and region. Urology 82:532–537CrossRefPubMed

18.

Kristal-Boneh E, Goffer D, Green MS (1994) Epidemiologic features of urolithiasis among industrial employees. The Israeli CORDIS Study. J Occup Med 36:1115–1119CrossRefPubMed

19.

Usman KD, Golan S, Abdin T, Livne PM, Pode D, Duvdevani M, Lifshitz D (2013) Urinary stone composition in Israel: current status and variation with age and sex–a bicenter study. J Endourol 27:1539–1542CrossRefPubMed

20.

Robertson WG, Hughes H (1994) Epidemiology of urinary stone disease in Saudi Arabi. In: Ryall R, Bais R, Marshall VR, Rofe AM, Smith LH, Walker VR (eds.) Urolithiasis 2. Plenum Press, New York and London, pp 453–455CrossRef

21.

Alkhunaizi AM (2016) Urinary stones in Eastern Saudi Arabia. Urol Ann 8:6–9CrossRefPubMedPubMedCentral

22.

Ketabchi AA, Aziziolahi GA (2008 Summer) Prevalence of symptomatic urinary calculi in Kerman, Iran. Urol J 5:156–160PubMed

23.

Mehrsai A, Taghizadeh Afshar A, Zohrevand R, Djaladat H, Steffes H, Hesse A, Pourmand G (2004) Evaluation of urinary calculi by infrared spectroscopy. Urol J 1:191–194PubMed

24.

Rizvi SAH, Naqvi SAA, Hussain Z, Hashmi A, Hussain M, Zafar MN, Mehdi H (2002) The management of stone disease. BJU Int 89(Suppl. 1):62–68CrossRefPubMed

25.

Rafique M, Bhutta RA, Rauf A, Chaudhry IA (2000) Chemical composition of upper renal tract calculi in Multan. J Pak Med Assoc 50:145–148PubMed

26.

Bakane BC, Nagtilak SB, Patil B (1999) Urolithiasis: a tribal scenario. Indian J Pediatr 66:863–865CrossRefPubMed

27.

Ansari MS, Gupta NP, Hemal AK, Dogra PN, Seth A, Aron M, Singh TP (2005) Spectrum of stone composition: structural analysis of 1050 upper urinary tract calculi from northern India. Int J Urol 12:12–16CrossRefPubMed

28.

Marickar YMF Epidemiology of stone disease in Kerala, South India. In Talati J, Tiselius H-G, Albala DM, Ye Z (eds.) Urolithiasis: basic science and clinical practice, Springer Verlag, London, pp 47–51

29.

Zeng Q, He Y (2013) Age-specific prevalence of kidney stones in Chinese urban inhabitants. Urolithiasis 41:91–93.CrossRefPubMed

30.

Wu W, Yang D, Tiselius HG, Ou L, Liang Y, Zhu H, Li S, Zeng G (2014) The characteristics of the stone and urine composition in Chinese stone formers: primary report of a single-center results. Urology 83:732–737CrossRefPubMed

31.

Huang WY, Chen YF, Carter S, Chang HC, Lan CF, Huang KH (2013) Epidemiology of upper urinary tract stone disease in a Taiwanese population: a nationwide, population based study. J Urol 189:2158–2163CrossRefPubMed

32.

Chou YH, Li CC, Wu WJ, Juan YS, Huang SP, Lee YC, Liu CC, Li WM, Huang CH, Chang AW (2007) Urinary stone analysis of 1000 patients in southern Taiwan. Kaohsiung J Med Sci 23:63–66CrossRefPubMed

33.

Yoshida O, Terai A, Ohkawa T, Okada Y (1999) National trend of the incidence of urolithiasis in Japan from 1965 to 1995. Kidney Int 56:1899–1904CrossRefPubMed

34.

Takahashi T, Yamane A, Okasho K, Yoshikawa T, Sawazaki H, Wataru S, Taki Y, Takeuchi H (2009) Incidence of upper urinary tract stone during 15 years in Tajima area, Japan: a hospital-based study. Urol Res 37:305–310CrossRefPubMed

35.

Kim Hh, Jo MK, Kwak C, Park SK, Yoo KY, Kang D, Lee C (2002) Prevalence and epidemiologic characteristics of urolithiasis in Seoul, Korea. Urology 59:517–521CrossRefPubMed

36.

Jeong JY, Doo SW, Yang WJ, Lee KW, Kim JM (2011) Differences in urinary stone composition according to body habitus. Korean J Urol 52:622–625CrossRefPubMedPubMedCentral

37.

Yanagawa M, Kawamura J, Onishi T, Soga N, Kameda K, Sriboonlue P, Prasongwattana V, Borwornpadungkitti S (1997) Incidence of urolithiasis in northeast Thailand. Int J Urol 4:537–540CrossRefPubMed

38.

Tanthanuch M, Apiwatgaroon A, Pripatnanont C (2005) Urinary tract calculi in southern Thailand. J Med Assoc Thai 88:80–85PubMed

39.

Alaya A, Hellara I, Belgith M, Nouri A, Hellara W, Neffati F, Saad H, Najjar MF (2012) Stone composition in the central coast Tunisian population. Prog Urol 22:938–944CrossRefPubMed

40.

Whalley NA, Moraes MF, Shar TG, Pretorius SS, Meyers AM (1998) Lithogenic risk factors in the urine of black and white subjects. Br J Urol 82:785–790CrossRefPubMed

41.

Rodgers A (2012) Epidemiology of stone disease in South Africa and Sub-Saharan Africa. In: Talati J, Tiselius H-G, Albala DM, Ye Z (eds.) Urolithiasis: basic science and clinical practice. Springer Verlag, London, pp 67–71CrossRef

42.

Lee MC, Bariol SV (2012) Epidemiology of stone disease in Australia. In: Talati J, Tiselius H-G, Albala DM, Ye Z (eds.) Urolithiasis: basic science and clinical practice. Springer Verlag, London, pp 73–76CrossRef

43.

Lee MC, Bariol SV (2013) Changes in upper urinary tract stone composition in Australia over the past 30 years. BJU Int 112(Suppl 2):65–68CrossRefPubMed

44.

Arias Vega MR, Pérula de Torres LA, Carrasco Valiente J, Requena Tapia MJ, Jiménez García C, Silva Ayçaguer LC (2016) Prevalence of urolithiasis in the 40 to 65 year old Spanish population: The PreLiRenE study. Med Clin (Barc) 146:525–531CrossRef

45.

De Miguel-Elízaga I, Martínez-Ruiz A, Avilés-Plaza F, Noguera-Velasco JA, Martínez-Hernández P, Parra-Pallarés S (2011) Kidney stones in a Mediterranean population from the south of Spain. Clin Chem Lab Med 50:545–548PubMed

46.

Giannossi ML, Mongelli G, Tateo F, Summa V (2012) Mineralogical and morphological investigation of kidney stones of a Mediterranean region (Basilicata, Italy). J Xray Sci Technol 20:175–186PubMed

47.

Ganesamoni R, Singh SK (2012) Epidemiology of stone disease in Northern India. In: Talati J, Tiselius H-G, Albala DM, Ye Z (eds.) Urolithiasis: basic science and clinical practice. Springer Verlag, London, pp 39–46CrossRef

48.

Nerli RB, Patil S, Hiremath MB, Patil RA (2014) Renal stone disease in the border regions of Karnataka, Maharashtra and Goa: Role of diet, urinary pH and body mass index. Indian. J Health Sci 7:83–87

49.

Luo D, Li H, Wang K (2012) Epidemiology of stone disease in China. In: Talati J, Tiselius H-G, Albala DM, Ye Z (eds.) Urolithiasis: basic science and clinical practice. Springer Verlag, London, pp 53–60CrossRef

50.

Hossain RZ, Ogawa Y, Hokama S, Morozumi M, Hatano T (2003) Urolithiasis in Okinawa, Japan: a relatively high prevalence of uric acid stones. Int J Urol 10:411–415CrossRefPubMed

51.

Beukes GJ, de Bruiyn H, Vermaak WJ (1987) Effect of changes in epidemiological factors on the composition and racial distribution of renal calculi. Br J Urol 60:387–392CrossRefPubMed

52.

Berkemeyer S, Vormann J, Gunther AL, Rylander R, Frassetto LA, Remer T (2008) Renal net acid excretion capacity is comparable in prepubescence, adolescence, and young adulthood but falls with aging. Am Geriatr Soc 56:1442–1448CrossRef

53.

Portis AJ, Hermans K, Culhane-Pera KA, Curhan GC (2004) Stone disease in the Hmong of Minnesota: initial description of a high-risk population. J Endourol 18:853–857CrossRefPubMed

54.

Trinchieri A (1996) Epidemiology of urolithiasis. Arch Ital Urol Androl 68:203–249PubMed

55.

Stuart RO 2nd, Hill K, Poindexter J, Pak CY (1991) Seasonal variations in urinary risk factors among patients with nephrolithiasis. J Lithotr Stone Dis 3:18–27PubMed

56.

Baker PW, Coyle P, Bais R, Rofe AM (1993) Influence of season, age, and sex on renal stone formation in South Australia. Med J Aust 159:390–392PubMed

57.

Choi HK, Curhan G (2008) Soft drinks, fructose consumption, and the risk of gout in men: prospective cohort study. BMJ 336:309–312CrossRefPubMedPubMedCentral

58.

Choi HK, Willett W, Curhan G (2007) Coffee consumption and risk of incident gout in men: a prospective study. Arthritis Rheum 56:2049–2055CrossRefPubMed

59.

Choi HK, Atkinson K, Karlson EW, Willett W, Curhan G (2004) Purine-rich foods, dairy and protein intake, and the risk of gout in men. N Engl J Med 350:1093–1103CrossRefPubMed

60.

Choi HK, Atkinson K, Karlson EW, Willett W, Curhan G (2004) Alcohol intake and risk of incident gout in men: a prospective study. The Lancet 363:1277–1281CrossRef

61.

Remer T, Manz F (1995) Potential renal acid load of foods and its influence on urine pH. J Am Diet Assoc 95:791–797CrossRefPubMed

62.

Trinchieri A, Croppi E, Montanari E (2016) Obesity and urolithiasis: evidence of regional influences. Urolithiasis. doi:10.1007/s00240-016-0908-3 PubMed

63.

Maalouf NM, Cameron MA, Moe OW, Adams-Huet B, Sakhaee K (2007) Low urine pH: a novel feature of the metabolic syndrome. Clin J Am Soc Nephrol 2:883–888CrossRefPubMed

64.

Cameron MA, Maalouf NM, Adams-Huet B, Moe OW, Sakhaee K (2006) Urine composition in type 2 diabetes: Predisposition to uric acid nephrolithiasis. J Am Soc Nephrol 17:1422–1428CrossRefPubMed

65.

Guariguata L, Whiting DR, Hambleton I, Beagley J, Linnenkamp U, Shaw JE (2010) Global estimates of diabetes prevalence for 2013 and projections for 2035. Diabetes Res Clin Pract 87:4–14CrossRef

66.

WHO Overweight and obesity. http://gamapserver.who.int/gho/interactive_charts/ncd/risk_factors/overweight/atlas.html. http://gamapserver.who.int/gho/interactive_charts/ncd/risk_factors/obesity/atlas.html

67.

Parks JH, Worcester EM, O’Connor RC, Coe FL (2003) Urine stone risk factors in nephrolithiasis patients with and without bowel disease. Kidney Int 63:255–265CrossRefPubMed

68.

Kaplan GG (2015) The global burden of IBD: from 2015 to 2025. Nature Reviews Gastroenterology Hepatology 12:720–727CrossRefPubMed

69.

Molodecky NA, Soon IS, Rabi DM, Ghali WA, Ferris M, Chernoff G, Benchimol EI, Panaccione R, Ghosh S, Berkema HW, Kaplan GG (2012) Increasing incidence and prevalence of the inflammatory bowel disease with time, based on systematic review. Gastroenterology 142:46–54CrossRefPubMed

70.

Trinchieri A, Lizzano R, Castelnuovo C, Zanetti G, Pisani E (2002) Urinary patterns of patients with renal stones associated with chronic inflammatory bowel disease. Arch Ital Urol Androl 74:61–64PubMed

Titel: Prevalence of renal uric acid stones in the adult
verfasst von: Alberto Trinchieri
Emanuele Montanari
Publikationsdatum: 03.03.2017
Verlag: Springer Berlin Heidelberg
Erschienen in: Urolithiasis / Ausgabe 6/2017
Print ISSN: 2194-7228
Elektronische ISSN: 2194-7236
DOI: https://doi.org/10.1007/s00240-017-0962-5

Neu im Fachgebiet Urologie

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

Stufenschema weist Prostatakarzinom zuverlässig nach

22.04.2024 Prostatakarzinom Nachrichten

Erst PSA-Test, dann Kallikrein-Score, schließlich MRT und Biopsie – ein vierstufiges Screening-Schema kann die Zahl der unnötigen Prostatabiopsien erheblich reduzieren: Die Hälfte der Männer, die in einer finnischen Studie eine Biopsie benötigten, hatte einen hochgradigen Tumor.

Harnwegsinfektprophylaxe: Es geht auch ohne Antibiotika

20.04.2024 EAU 2024 Kongressbericht

Beim chronischen Harnwegsinfekt bei Frauen wird bisher meist eine Antibiotikaprophylaxe eingesetzt. Angesichts der zunehmenden Antibiotikaresistenz erweist sich das Antiseptikum Methenamin-Hippurat als vielversprechende Alternative, so die Auswertung einer randomisierten kontrollierten Studie.

Update Urologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 6/2017

Comparison of supine and prone positions for percutaneous nephrolithotomy in treatment of staghorn stones

Systemic endothelial function measured by flow-mediated dilation is impaired in patients with urolithiasis

The effect of nephrostomy tract infiltration of ketamine on postoperative pain and peak expiratory flow rate in patients undergoing tubeless percutaneous nephrolithotomy: a prospective randomized clinical trial

The impact of ureteral stent indwelling time on the treatment of acute infection caused by ureteral calculi